Stakeholders seek clarity, use of international standards in FDA protocol deviations guidance
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesClinical Trials Regulation GuidanceICHISOMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyStandardsUnited StatesUS Food and Drug Administration (FDA)